Pseudomonas aeruginosa in neonatal intensive care units
Written by Y.B.Raoab†Z.X.Renab†J.J.ZhongaX.M.ZhongabB.CaocD.M.ChendX.N.PaneY.P.JiafP.M.GaogB.Y.YanghQ.ZhongiJ.YangaRisk factors for imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units in south China
Summary
This multi-centre retrospective study was designed to investigate the risk factors for infection with imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units (NICUs) in south China. All patients with confirmed P. aeruginosa infection from eight NICUs in south China were divided into two groups: imipenem-susceptible P. aeruginosa and imipenem-resistant P. aeruginosa. Data were analysed using Chi-squared test and logistic regression. In total, 188 medical records were reviewed. On multi-variate logistic analysis, the only independent risk factor was imipenem treatment within two weeks of isolation of P. aeruginosa (odds ratio 6.409, 95% confidence interval 1.926–21.333).
https://www.sciencedirect.com/science/article/pii/S0195670117306928
BOHS P901 Legionella Management and Control in Building Hot & Cold Water Services
Written by Czakó Dániel – Legionella és Pseudomonas kockázatértékelési szakértőMost recent certificates obtained
BOHS P901 Legionella Management and Control in Building Hot & Cold Water Services 16th August 2019
DBS - 4th August 2019
CITB - Health, safety and environment test for operatives - English-UK (ENG) 2nd September 2019
Level 2 Award for Working in Low Risk Confined Spaces 8th July 2019
Quarterly in-house trainings between 2010 - 2018